4- years results of weekly trastuzumab and paklitaxel in the treatment with women with HER2/neu overexpressing advanced breast cancor: singl prospective study | Charles Explorer

4- years results of weekly trastuzumab and paklitaxel in the treatment with women with HER2/neu overexpressing advanced breast cancor: singl prospective study

Publikace na 1. lékařská fakulta |

2004

Abstrakt

breast cancer, HER2/Neu overexpression, transtuzumab, paklitaxel

Osoby